Merged Big Pharma Will Need More Biotech Products - Jurgen Drews
Executive Summary
The larger pharmaceutical companies created in the current merger environment will require even more products from the biotechnology industry, International Biomedicine Management Partners Chairman Jurgen Drews, MD, maintained at the Biotechnology Industry Organization CEO & Investor Conference Feb. 15 in New York City.